These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7104170)

  • 1. Plasma levels of (+) and (-)-propranolol and 4-hydroxypropranolol after administration of racemic (+/-)-propranolol in man.
    Von Bahr C; Hermansson J; Tawara K
    Br J Clin Pharmacol; 1982 Jul; 14(1):79-82. PubMed ID: 7104170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Hydroxypropranolol and its glucuronide after single and long-term doses of propranolol.
    Walle T; Conradi EC; Walle UK; Fagan TC; Gaffney TE
    Clin Pharmacol Ther; 1980 Jan; 27(1):22-31. PubMed ID: 7351114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol plasma levels and relief of migraine. Relationship between plasma propranolol and 4-hydroxypropranolol concentrations and clinical effects.
    Cortelli P; Sacquegna T; Albani F; Baldrati A; D'Alessandro R; Baruzzi A; Lugaresi E
    Arch Neurol; 1985 Jan; 42(1):46-8. PubMed ID: 3966884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cholestyramine and colestipol on the plasma concentrations of propranolol.
    Hibbard DM; Peters JR; Hunninghake DB
    Br J Clin Pharmacol; 1984 Sep; 18(3):337-42. PubMed ID: 6487473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations of propranolol and 4-hydroxypropranolol during chronic oral propranolol therapy.
    Wong L; Nation RL; Chiou WL; Mehta PK
    Br J Clin Pharmacol; 1979 Aug; 8(2):163-7. PubMed ID: 486291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A radioreceptor assay for propranolol and 4-hydroxypropranolol.
    Rochester CL; Gammon DE; Shane E; Bilezikian JP
    Clin Pharmacol Ther; 1980 Jul; 28(1):32-9. PubMed ID: 6248289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of propranolol, 4-hydroxypropranolol and propranolol glycol in human plasma.
    Schneck DW; Pritchard JF; Hayes AH
    Res Commun Chem Pathol Pharmacol; 1979 Apr; 24(1):3-12. PubMed ID: 432438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of propranolol and 4-hydroxypropranolol enantiomers after chiral derivatization using reversed-phase high-performance liquid chromatography.
    Schaefer HG; Spahn H; Lopez LM; Derendorf H
    J Chromatogr; 1990 May; 527(2):351-9. PubMed ID: 2387882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatographic determination of propranolol and 4-hydroxypropranolol in plasma.
    Rosseel MT; Bogaert MG
    J Pharm Sci; 1981 Jun; 70(6):688-9. PubMed ID: 7252820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.
    Coltart DJ; Shand DG
    Br Med J; 1970 Sep; 3(5725):731-4. PubMed ID: 4394650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined high-performance liquid chromatographic procedure for measuring 4-hydroxypropranolol and propranolol in plasma: pharmacokinetic measurements following conventional and slow-release propranolol administration.
    Drummer OH; McNeil J; Pritchard E; Louis WJ
    J Pharm Sci; 1981 Sep; 70(9):1030-2. PubMed ID: 6101148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatographic assay for the derivatized enantiomers of propranolol and 4-hydroxypropranolol in human plasma.
    Miller RB
    J Pharm Biomed Anal; 1991; 9(10-12):953-8. PubMed ID: 1822218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine methods in toxicology and therapeutic drug monitoring by high-performance liquid chromatography. IV. A rapid microscale method for determination of propranolol and 4-hydroxypropranolol in plasma.
    Sood SP; Green VI; Mason RP
    Ther Drug Monit; 1988; 10(2):224-30. PubMed ID: 3381242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No stereoselective first-pass hepatic extraction of propranolol.
    Jackman GP; McLean AJ; Jennings GL; Bobik A
    Clin Pharmacol Ther; 1981 Sep; 30(3):291-6. PubMed ID: 7273593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of propranolol and 4-hydroxypropranolol in human plasma by high-performance liquid chromatography.
    Fu CW; Mason WD
    Analyst; 1989 Oct; 114(10):1219-23. PubMed ID: 2619067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-pressure liquid chromatographic method for the simultaneous quantitative analysis of propranolol and 4-hydroxypropranolol in plasma.
    Nation RL; Peng GW; Chiou WL
    J Chromatogr; 1978 May; 145(3):429-36. PubMed ID: 659528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of propranolol and 4-hydroxypropranolol in plasma by mass fragmentography.
    Walle T; Morrison J; Walle K; Conradi E
    J Chromatogr; 1975 Nov; 114(2):351-9. PubMed ID: 417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racemic (R,S)-propranolol versus half-dosed optically pure (S)-propranolol in humans at steady state: Hemodynamic effects, plasma concentrations, and influence on thyroid hormone levels.
    Stoschitzky K; Lindner W; Egginger G; Brunner F; Obermayer-Pietsch B; Passath A; Klein W
    Clin Pharmacol Ther; 1992 Apr; 51(4):445-53. PubMed ID: 1563214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphic ability to metabolize propranolol alters 4-hydroxypropranolol levels but not beta blockade.
    Raghuram TC; Koshakji RP; Wilkinson GR; Wood AJ
    Clin Pharmacol Ther; 1984 Jul; 36(1):51-6. PubMed ID: 6734049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels and beta-adrenoceptor blockade with acebutolol, practolol and propranolol in man.
    Cuthbert MF; Collins RF
    Br J Clin Pharmacol; 1975 Feb; 2(1):49-55. PubMed ID: 1234486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.